Stevanato Group Acquires Optrel

The use of Optrel technology ultimately strengthens the position of OMPI as a world leader in the production of high quality glass delivery systems for the Pharmaceutical Industry.



“The Optrel purchase” said Sergio Stevanato, CEO of the Group, “is part of the development project of the Group, initiated with the strengthening of the Glass division through the acquisition of Alfamatic and Medical Glass, and in perspective of the development of the Engineering division, in total synergy with the SPAMI product line”.

“The Group intends to widen our product line to offer systems for the automated control of dimensional and cosmetic aspects of glass containers used by the Pharmaceutical Industry. These new systems, which will be effective on both empty glass containers as well as those filled with final product, will be available to Pharmaceutical companies and glass container producers”.

The Stevanato Group is a global leader in primary packaging for pharmaceutical use. The Group has 850 employees and sales in excess of 115 million euros, 70% derived from Europe, USA and Australia. Group companies include Nuova Ompi (Italy), Alfamatic (Italy), Medical Glass (Bratislava, Slovakia), Spami (Italy) and Optrel (Italy).



The purchase of Optrel confirms our commitment to strengthen our position in the world market by providing first class production capabilities. In this perspective of growth, in particular in the American market, we have initiated the construction of a new production site for glass containers in Mexico in order to more effectively serve North America.

About Stevanato Group



Founded in 1949 Stevanato Group is one of the world’s leading manufacturers of containers from glass tubing and since the beginning it was self-sufficient in developing the technology and producing the machinery for the manufacture of containers from glass tubing.



The Company is made up of two divisions:

The Glass Division specialized in the primary packaging from glass tubing for cosmetic and pharmaceutical use, includes Nuova Ompi (the largest Division of the Group) , Ompi N. America, Alfamatic and Medical Glass

The Engineering Division that designs and builds machineries for the production and control of glass tubing containers, includes S.P.A.M.I and Optrel.

Stevanato Group offers the complete range of pharmaceutical containers deriving from glass tubing (ampoules; screw neck, pilfer proof, blow back and pill vials; dental and pen cartridges; syringes with needle/without needle; special devices).

Having developed inside since ’70 the technology for all the production systems (machines, auto adjusting system, software, control systems) Stevanato Group is not only independent from this point of view but it is, thanks to the work of a R&D team, always forefront in the study and implementation of solutions of specific systems for the glass containers production.

Stevanato Group reachs over than 60 countries assuring quality and innovation to 300 customers to whom S.G sells more than 1.6 billion glass containers per year.

-----------

Key Data

Employees: 850

Production: 1.6 MM pcs

Sales 2006: 115 MM Euro

Investements 2007: 23 MM Euro

----------

Contacts

gabriele.peron@ompi.it